01—Abstract
Summary
Summary of the 8-K filed September 4, 2025. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. (ELV) has issued a Current Report (8-K) on September 4, 2025, primarily to reaffirm its financial guidance for the full year 2025.
The company expects to report diluted earnings per share of approximately $24.10a, which includes an estimated $5.90 per diluted share in net unfavorable items. Excluding these specific items, the adjusted earnings per share are projected to be around $30.00, consistent with prior disclosures and not accounting for any additional adjustments beyond those already reported in the second quarter of 2025. Furthermore, Elevance Health is reiterating its guidance for the full year 2025 benefit expense ratio, which is anticipated to be approximately 90.0%.
Management attributes these expectations to their current assessment of market conditions, operational performance, the regulatory and policy environment, and refined assumptions regarding cost trends and medical claims payable estimates. Investors are cautioned that actual results may differ materially due to changes in these factors.
02—Key points
Key Highlights
- Reaffirmation of 2025 diluted earnings per share guidance at approximately $24.10.
- Expectation of approximately $5.90 per diluted share in net unfavorable items for 2025.
- Projection of 2025 adjusted shareholders' earnings per diluted share to be approximately $30.00.
- Reaffirmation of 2025 benefit expense ratio guidance at approximately 90.0%.
- Guidance reflects management's current view of market conditions, operational performance, and regulatory landscape.
- No new financial guidance or material updates beyond reaffirmation are provided in this filing.
- The company emphasizes that actual results could differ materially from current expectations.
03—Questions
Frequently Asked Questions
What is the main purpose of this 8-K filing from Elevance Health?
The primary purpose of this 8-K filing is to reaffirm Elevance Health's previously issued financial guidance for the full fiscal year 2025 to investors during upcoming meetings. It confirms expected earnings per share and benefit expense ratio.
What are the key financial figures being reaffirmed for 2025?
Elevance Health is reaffirming its guidance for full-year 2025 diluted earnings per share to be approximately $24.10, including about $5.90 of net unfavorable items. The adjusted earnings per diluted share are expected to be around $30.00. The benefit expense ratio is expected to be approximately 90.0%.
Does this filing introduce any new financial guidance or significant updates?
No, this filing does not introduce any new financial guidance or material updates. It serves to reaffirm existing expectations and guidance provided previously, particularly in light of upcoming investor interactions.
What factors influence Elevance Health's current financial expectations?
Management's current expectations are based on their view of market conditions, operational performance, the regulatory and policy landscape, and refinements in key business assumptions, including cost trends and medical claims payable estimates.
04—Continue